Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.100 |
None |
0.944 |
18 |
1
|
2003 |
2019 |
Differentiated Thyroid Gland Carcinoma
|
disease |
|
Neoplastic Process
|
245
|
80
|
0.050 |
None |
1.000 |
5 |
1
|
2005 |
2016 |
Primary differentiated carcinoma of thyroid gland
|
disease |
|
Neoplastic Process
|
167
|
41
|
0.040 |
None |
1.000 |
4 |
1
|
2005 |
2016 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Uric acid measurement (procedure)
|
phenotype |
|
Laboratory Procedure
|
264
|
1463
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Carcinoma breast stage IV
|
disease |
|
Neoplastic Process
|
573
|
14
|
0.010 |
None |
1.000 |
1 |
1
|
2006 |
2006 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
premalignant lesion
|
phenotype |
|
Neoplastic Process
|
20
|
5
|
0.010 |
None |
< 0.001 |
1 |
1
|
2005 |
2005 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Single tumor
|
phenotype |
|
Neoplastic Process
|
63
|
4
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Carcinoma of supraglottis
|
disease |
|
Neoplastic Process
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Gastric Cardia Adenocarcinoma
|
disease |
|
Neoplastic Process
|
65
|
11
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6
|
phenotype |
|
Finding
|
2
|
1
|
0.600 |
None |
1.000 |
1 |
1
|
2000 |
2000 |
Somatic mutation
|
phenotype |
|
Cell or Molecular Dysfunction
|
151
|
|
0.100 |
None |
|
0 |
|
|
|
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.020 |
None |
1.000 |
2 |
1
|
2013 |
2014 |
Lead Poisoning
|
disease |
Chemically-Induced Disorders
|
Injury or Poisoning
|
9
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Congenital chromosomal disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
757
|
47
|
0.100 |
None |
1.000 |
12 |
|
2004 |
2012 |
Dystrophia myotonica 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
118
|
21
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Dysplastic Nevus Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Xeroderma Pigmentosum, Complementation Group D
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
70
|
111
|
0.100 |
None |
0.750 |
12 |
3
|
2003 |
2016 |
Xeroderma Pigmentosum
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
137
|
35
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2014 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome; Congenital Abnormality
|
69
|
82
|
0.020 |
None |
1.000 |
2 |
1
|
2004 |
2005 |
Xeroderma pigmentosum, group A
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
48
|
55
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Fanconi Anemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
394
|
173
|
0.020 |
None |
1.000 |
2 |
|
1992 |
2019 |
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
360
|
194
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |